Literature DB >> 3260179

Gamma camera emission tomography using radiolabelled antibodies.

A C Perkins1, D R Whalley, K C Ballantyne, M V Pimm.   

Abstract

Single photon emission computed tomography (SPECT) of 52 patients injected with 131I and 111In labelled monoclonal antibodies has been undertaken. Patients with tumours within the thorax or lower abdomen were imaged 48-72 h following administration of 80 MBq 131I or 111In labelled monoclonal antibody. Tumour detection from the reconstructed views was compared with that from the planar images. Studies of patients injected with 131I labelled antibodies required long data collection times otherwise image quality was unsatisfactory. Emission tomography using 111In labelled antibodies provided high quality reconstructed images using data collection times acceptable for most patients, and tumour deposits not confidently detected on planar images were clearly visualised in the axial views. These studies demonstrate the potential of radiolabelled antibody emission tomography.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260179     DOI: 10.1007/bf00252618

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  19 in total

Review 1.  Monoclonal antibodies in nuclear medicine.

Authors:  A M Keenan; J C Harbert; S M Larson
Journal:  J Nucl Med       Date:  1985-05       Impact factor: 10.057

2.  The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.

Authors:  A C Perkins; M V Pimm; M K Birch
Journal:  Eur J Nucl Med       Date:  1985

3.  Gamma camera emission tomography. Development and properties of a multi-sectional emission computed tomography system.

Authors:  S A Larsson
Journal:  Acta Radiol Suppl       Date:  1980

4.  In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.

Authors:  M V Pimm; M J Embleton; A C Perkins; M R Price; R A Robins; G R Robinson; R W Baldwin
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

5.  Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody.

Authors:  P A Farrands; A C Perkins; M V Pimm; M J Embleton; J D Hardy; R W Baldwin; J D Hardcastle
Journal:  Lancet       Date:  1982-08-21       Impact factor: 79.321

6.  Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.

Authors:  A A Epenetos; K E Britton; S Mather; J Shepherd; M Granowska; J Taylor-Papadimitriou; C C Nimmon; H Durbin; L R Hawkins; J S Malpas; W F Bodmer
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

7.  The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours.

Authors:  N C Armitage; A C Perkins; M V Pimm; P A Farrands; R W Baldwin; J D Hardcastle
Journal:  Br J Surg       Date:  1984-06       Impact factor: 6.939

8.  Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.

Authors:  E M Symonds; A C Perkins; M V Pimm; R W Baldwin; J G Hardy; D A Williams
Journal:  Br J Obstet Gynaecol       Date:  1985-03

9.  Analysis of radioimmunodetection of tumors by the subtraction technique.

Authors:  A J Green; R H Begent; P A Keep; K D Bagshawe
Journal:  J Nucl Med       Date:  1984-01       Impact factor: 10.057

10.  The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast.

Authors:  M R Williams; A C Perkins; F C Campbell; M V Pimm; J G Hardy; M L Wastie; R W Blamey; R W Baldwin
Journal:  Clin Oncol       Date:  1984-12
View more
  6 in total

1.  Early immunoscintigraphic localisation of a mediastinal tumour with indium 111-DTPA CEA-specific F(ab')2 monoclonal antibody fragments (BW 431/31) using second tracer isocontour technique.

Authors:  J Frohn; R P Baum; J Happ; S Falk; H E Riemann; G Hör
Journal:  Eur J Nucl Med       Date:  1990

2.  A prospective evaluation of OC125 and magnetic resonance imaging in patients with ovarian carcinoma.

Authors:  A C Perkins; M C Powell; M L Wastie; I V Scott; A Hitchcock; B S Worthington; E M Symonds
Journal:  Eur J Nucl Med       Date:  1990

3.  Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.

Authors:  A Chetanneau; R P Baum; P A Lehur; J C Liehn; A C Perkins; R Bares; P Bourguet; J Y Herry; J C Saccavini; J F Chatal
Journal:  Eur J Nucl Med       Date:  1990

Review 4.  Nuclear medicine studies in the differential diagnosis of diseases with spinal involvement.

Authors:  K Didion; B Nägele-Wöhrle; T Schaub; K Hahn
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

5.  Radioimmunoscintigraphy of CEA/CA 19-9 producing tumors with I-131 labeled monoclonal antibodies.

Authors:  A S Arbab; K Koizumi; G Uchiyama; T Arai; H Eguchi; Y Matsumoto; K Suda
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

6.  Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer.

Authors:  M Granowska; K E Britton; S J Mather; G Morris; D Ellison; S Soobramoney; I C Talbot; J M Northover
Journal:  Eur J Nucl Med       Date:  1993-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.